Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 214925

QID 214925 (Type "214925" in App Search)
A pharmaceutical company is testing the efficacy of a novel lipid-lowering therapy called drug ABC101. Drug ABC101 was administered to a sample of 2,000 volunteers with moderate hyperlipidemia and the reduction in low-density lipoprotein (LDL) cholesterol was measured. The reduction in LDL cholesterol in this sample followed a normal distribution with a mean of 5.5 mg/dL and a standard deviation of 1.5 mg/dL. The pharmaceutical company is targeting a reduction in LDL cholesterol of at least 8.5 mg/dL and needs to provide an estimate of the efficacy of drug ABC101 for regulatory review. Approximately how many patients in this sample achieved the company’s target for LDL cholesterol reduction?